Author: Business Wire

Avedro annonce le recrutement du premier patient dans l’essai pivot de phase 3 épi-on sur la réticulation cornéenne pour le kératocône progressif aux États-Unis

WALTHAM, Massachusetts–(BUSINESS WIRE)–Avedro, Inc., une société de produits pharmaceutiques ophtalmiques et d’appareils médicaux qui est aussi le leader mondial du remodelage de la cornée, a annoncé aujourd’hui avoir démarré le recrutement de patients dans le cadre d’un essai clinique pivot de Phase 3 visant à évaluer l’innocuité et l’efficacité d’un procédé de réticulation du collagène de la cornée épithélium-on (épi-on) pour traiter les patients atteints d’un kératocône progressif. Le kéra

Aerie Pharmaceuticals Announces Appointment of William Coppola as Intellectual Property Counsel

DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma and other diseases of the eye, today announced the appointment of William Coppola as Intellectual Property Counsel, reporting to John LaRocca, Aerie’s General Counsel. Mr. Coppola will oversee intellectual property matters both domestically and

CMS Issues Preliminary Decision on Unique J Code for Avedro Photrexa® Drug Formulations

WALTHAM, Mass.–(BUSINESS WIRE)–Avedro, Inc., an ophthalmic pharmaceutical and medical device company and world leader in corneal remodeling, today announced that the Centers for Medicare and Medicaid Services (CMS) has issued a preliminary decision to establish a product specific Healthcare Common Procedure Coding System (HCPCS) J code for Photrexa® drug formulations. Claims submitted with a product specific J code are generally processed more efficiently than claims using a miscellaneous cod

EyeSouth Establishes a Presence in South Georgia and North Florida Through a Strategic Partnership with South Georgia / North Florida Eye Partners

ATLANTA–(BUSINESS WIRE)–EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce that it has completed a strategic partnership with South Georgia / North Florida Eye Partners and Cataract and Laser Surgery Center of South Georgia (“South Georgia Eye”), expanding its presence into the South Georgia and North Florida regions. EyeSouth is an eye care-focused physician services organization formed by Shore Capital Partners, a leading lower middle market healthcare private equity fir